Core C: High Dimensional Cellular and Spatial Analysis
- Institution
- FRED HUTCHINSON CANCER CENTER, WA
- Principal investigator
- Evan Newell
- Funding
- $659K
- Duration
- 1997–2029
Moonbase score
Still being scored
Abstract
Project Summary/Abstract Recent advances in single-cell genomic and high content spatial analysis technologies have shed new light on organ and tissue composition, delineating complex tissues and identifying new cell types. However, the data generated by these approaches are becoming increasingly complex. The High Dimensional Cellular and Spatial Analysis Core (HDCSAC – Core C) will work with each project and the Biostatistics and Data Management Core to facilitate the efficient use of single-cell sequencing, high-dimensional tissue imaging, including spatial- transcriptomics, and will oversee the integrated exploratory analysis of high-dimensional datasets. In addition to assisting in testing hypotheses generated by each of the projects, a major role for this core will be to use data- driven approaches for discovery and hypothesis generation. The roles of this core will be split into three aims: For Aim 1, we will support the efficient use of single-cell sequencing across projects. A major focus will be on the use of the 10x Genomics 5’ capture immune profiling platform, which allows for simultaneous detailed profiling of cellular protein (using oligonucleotide tagged antibodies, a.k.a. CITEseq), mRNA, and paired ⍺βTCR sequencing. For Aim 2, we will work with the Fred Hutch Experimental Histopathology core to coordinate multiplex- immunohistochemistry (mIHC) data acquisition and analysis. We will also leverage our recent experience in the use of new and emerging in situ spatial transcriptomics methods to enable novel hypothesis generation and testing related to the detailed architecture of tumor microenvironment within the bone marrow. Lastly, for Aim 3, we will support integrated analysis of flow cytometry and other high-dimensional datasets generated by this Core and each program project.
LOADING MOONBASE SCORE
Questions for FRED HUTCHINSON CANCER CENTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Fred Hutchinson Cancer CenterNot yet scored
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma
Evan Newell · $616K · 2021–2026
- NIH · Fred Hutchinson Cancer Center50
Ustekinumab for Graft versus Host Disease Prevention (IND 144540)
Stephanie J Lee · $877K · 2020–2026
- NIH · Fred Hutchinson Cancer Center47
Forecasting influenza evolution on a heterogeneous immune landscape
Trevor Bc Bedford · $744K · 2022–2028